Posted inClinical Updates Neurology news
Eptinezumab Combined with Patient Education for Chronic Migraine and Medication-Overuse Headache: Insights from the RESOLUTION Trial
The Phase 4 RESOLUTION trial demonstrates that eptinezumab 100 mg IV, combined with standardized patient education, significantly reduces migraine frequency and acute medication reliance in adults with comorbid chronic migraine and medication-overuse headache.